PATH vs PETS
Uipath Inc (PATH) versus PetMed Express Inc (PETS) — a side-by-side from cached financials, not a winner call.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
PetMed Express Inc (PETS) is a pharmaceutical retailers company listed on NASDAQ.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Latest reported PETS revenue for 2025-03-31 was $227.0M. Net income was -$6.3M. PETS currently screens at market cap $38.5M.
PATH currently screens at market cap $6.07B and trailing P/E 19.4. PETS currently screens at market cap $38.5M.
Not investment advice. Open the PATH and PETS stock pages for the full models.
Not investment advice.